kr542.00
1.12% today
Stockholm, Nov 20, 05:29 pm CET
ISIN
SE0009160872
Symbol
MCAP

MedCap AB Stock price

kr536.00
-19.00 3.42% 1M
+92.00 20.72% 6M
-65.00 10.82% YTD
+11.00 2.10% 1Y
+328.50 158.31% 3Y
+335.00 166.67% 5Y
+517.60 2,813.04% 10Y
+525.90 5,206.93% 20Y
Stockholm, Closing price Wed, Nov 19 2025
+5.00 0.94%

New AI Insights on MedCap AB Insights AI Insights on MedCap AB

What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
kr8.0b
Enterprise Value
kr8.1b
Net debt
kr147.4m
Cash
kr358.7m
Shares outstanding
15.0m
Valuation (TTM | estimate)
P/E
40.9 | 36.3
P/S
4.0 | 3.4
EV/Sales
4.1 | 3.5
EV/FCF
31.5
P/B
5.7
Financial Health
Equity Ratio
64.4%
Return on Equity
16.2%
ROCE
13.2%
ROIC
11.8%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
kr2.0b | kr2.3b
EBITDA
kr402.5m | kr438.1m
EBIT
kr270.7m | kr299.4m
Net Income
kr196.9m | kr221.2m
Free Cash Flow
kr258.5m
Growth (TTM | estimate)
Revenue
11.3% | 28.7%
EBITDA
-0.7% | 13.0%
EBIT
-8.0% | 9.9%
Net Income
-13.6% | 6.7%
Free Cash Flow
3.2%
Margin (TTM | estimate)
Gross
58.1%
EBITDA
20.2% | 18.8%
EBIT
13.6%
Net
9.9% | 9.5%
Free Cash Flow
13.0%
More
EPS
kr13.1
FCF per Share
kr17.2
Short interest
-
Employees
592
Rev per Employee
kr3.1m
Show more

Is MedCap AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

MedCap AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MedCap AB forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a MedCap AB forecast:

Buy
86%
Hold
14%

Financial data from MedCap AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,991 1,991
11% 11%
100%
- Direct Costs 835 835
13% 13%
42%
1,156 1,156
39% 39%
58%
- Selling and Administrative Expenses 518 518
14% 14%
26%
- Research and Development Expense - -
-
-
403 403
1% 1%
20%
- Depreciation and Amortization 132 132
19% 19%
7%
EBIT (Operating Income) EBIT 271 271
8% 8%
14%
Net Profit 197 197
14% 14%
10%

In millions SEK.

Don't miss a Thing! We will send you all news about MedCap AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Stockholm, Stockholm and currently employs 583 full-time employees. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

Head office Sweden
Employees 592
Website www.medcap.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today